<<...reminds me another "one trick pony" Elan (ELN). I used to trade it well below $10 when it had problems with FDA. Just noticed, it's a $35 now (!)>>
That's why biotechs are scary: "On Friday, Massachusetts-based Biogen (nasdaq: BIIB - news - people ) and Dublin-based Elan's (nyse: ELN - news - people ) shares took a nosedive after the companies announced in a regulatory filing late Thursday that two new cases of a rare brain disease were found in patients taking its multiple sclerosis (MS) drug Tysabri." http://www.forbes.com/2008/08/01/biogen-elan-update-markets-equity-cx_ra_0801markets28.html?partner=yahootix